The EMA has recommended label expansions for Inaqovi, Opdivo, and Venclyxto, broadening treatment options in AML, Hodgkin lymphoma, and CLL.

Today’s announcement by Local Government Minister Simon Watts and RMA Reform & Infrastructure Minister Chris Bishop to make ...

Gold breakout trading blends technical precision with risk control to capture major price moves. From EMA and Donchian channels to session timing, traders use structured setups to filter false signals ...

The European Commission will on Wednesday ask EU countries to eradicate poverty, arguing that governments can access the ...

Explore key questions on contamination control strategies to support regulatory compliance and risk management in ...

The EMA has recommended updating Comirnaty 10 mg formulations, including JN.1, KP.2, and LP.8.1 versions, to allow COVID-19 vaccination in individuals aged 6 months or older.

On April 28, 2026, the FDA advanced multiple initiatives that could significantly alter drug development, approval, and ...

Housing Forward and the City of Dallas Office of Emergency Management say they will continue the strategy that metrics show ...

In January 2026, FDA issued draft guidance that expanded the potential use of real-world evidence (RWE) during the clinical ...

For pharmaceutical and life sciences companies ready to embrace this moment, the 10 principles aren't a burden. They're a ...

The approved brand name will be publicly disclosed following EMA approval of the corresponding pharmaceutical product. This reflects standard regulatory practice, in which brand names are reviewed in ...

From 2019 through now, Amneal revenues have grown 11% and adjusted EBITDA has grown 13% on a CAGR basis. With growth in each ...